Elevating Expectations


Today’s labs are experiencing rising sample volumes, increasing test complexity, and various labor-related constraints. These create delays between sample and answer, causing unnecessary lags in care delivery times, impacting patient care, and straining financials.  


Beckman Coulter’s Advantaged Workflows combine products, services, and expertise that accelerate more precise clinical decision-making—from sample collection to diagnostic insight—unlocking the power of every sample and improving workflow to create new value for your laboratory teams.


We start by providing highly robust and reliable clinical insights from reduced pre-analytic errors, a broad assay menu, including assay innovation, and high-sensitivity analyzers. Our modern approaches to automation, integration, middleware, service, and proven expertise in continuous improvement ensure that we stay ahead of unnecessary downtimes to enhance workflow quality and maximize uptime at scale.

A Powerful Combination

Streamlined Operations and Workflow Optimization

Standardized processes and automation eliminate unnecessary errors, manual touchpoints, and repetitive steps for your team.

  • Drive significant reduction in turnaround times with lab automation scaled to fit your unique needs. The DxA 5000 Total Lab Automation System completes 98% of samples in less than 40 minutes (95th percentile at 38 minutes).
  • Set a new standard for productivity with the DxI 9000 Immunoassay Analyzer, including minimal maintenance requirements, real-time error detection, and the real-time instrument monitoring and predictive analytics.
  • Simplify staff and workload planning with predictable workflows. Reclaim >2,400 hours in your hematology lab per year by decreasing slide reviews.1






Flexible Instrumentation
and Scalable Automation

Instruments and automation systems designed to adapt to labs of all sizes, along with industry-leading expertise, ensure optimal performance across varying volumes and complexity.

  • With scalability and commutability with one family of analyzers, standardized reagents can be used across instrument platforms, providing commutable results across labs and streamlined training for medical technicians and operators.
  • FlexMode Operations with the DxC 500i Clinical Analyzer allows you independent maintenance, running tests on one side of the analyzer while performing maintenance on the other. It also provides dynamic sample handling, prioritizing immunoassay and chemistry testing according to each sample’s urgency — no need for operator intervention or separate loading.






"When considering vendors for instrumentation, our long-standing relationship with Beckman Coulter was a critical factor in our decision. We knew we could count on multidimensional support for implementation and validation, as well as reliable service for our new and existing instruments during the transition." 

 

Brittany Bedel MSHA, MLS (ASCP)CM

Director, Laboratory Operations
Bethesda North Hospital


Integrated IT and Middleware

 

Advanced IT systems and middleware drive productivity by streamlining workflow integration, enhancing test utilization, and supporting interoperable and intelligent decision making.

  • Take Control with REMISOL Advance Middleware. The rule-writing engine enables sophisticated rule creation, including Quality Assurance, Delta Checks, Standard Reference Ranges, Reflex Testing, Dilution Protocols, and Rerun Criteria. It allows for detailed rule-building for Chemistry, Hematology, and Immunoassay.
  • Gain dynamic communication and unprecedented control over your testing management. REMISOL Advance also provides system constraints to the DxA 5000 Automation System to algorithmically power ‘Intelligent’ Sample Routing.

Advancing Clinical Capabilities

Built on a broad, ever-expanding and innovative assay menu, as well as utilizing high-sensitivity analyzers, we maximize the utility of every sample and deliver clinician-ready results with minimal variability.


  • A robust menu of diagnostic and prognostic biomarkers, including in Cardiac Care, Infectious Disease, Women’s Health, and Neurology
  • High-sensitivity assays that deliver fewer false positives, detect disease earlier and provide greater confidence in results




1. Data drawn from side-by-side evaluation of flagging performance and low confidence results (R for DxH - Beckman Coulter and * for XN - Sysmex), based on 11 hospitals and N=1633 samples.

 2025-13903